Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate in Adults With Mild Symptoms of COVID-19
NCT04387240Phase 2Withdrawn
- Sponsor
- Princess Nourah bint Abdulrahman University
- Start
- Jan 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artesunate in coronavirus disease 2019 (COVID-19), sponsored by Princess Nourah bint Abdulrahman University. Planned start Jan 2022; status: withdrawn.
02
Drugs
artesunate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04387240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04387240.